Thursday Morning Live Cases: Coronary and Structural Interventions
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided...Read More
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided training for thousands of interventional cardiologists from the United States and abroad since 1981.
The meeting’s mission is to engage interventional cardiologists and cardiac surgeons specializing in coronary and structural heart disease to further enhance the care of their patients, mentor and train future generations of cardiovascular specialists, and lead front-line clinical research in the field.
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally...
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.
Dr. James Harvey, MD, FACC is an Interventional Cardiologist with WellSpan Health. He attended undergraduate and...
Dr. James Harvey, MD, FACC is an Interventional Cardiologist with WellSpan Health. He attended undergraduate and graduate school at Vanderbilt University and then went to medical school at the University of South Florida College of Medicine. Dr. Harvey then did his residency training in Internal Medicine at Emory University Hospital in Atlanta, GA and completed fellowship training in both Cardiovascular Medicine and Interventional Cardiology at the Cleveland Clinic in Cleveland, OH where he served as the chief interventional fellow. Board-certified in Cardiovascular Medicine and Interventional Cardiology, Dr. Harvey has a special interest in structural and valvular heart disease, complex coronary artery disease, and mechanical cardiovascular circulatory support. He is the Director of the Cardiac Catheterization Laboratory and the Structural Heart Program at WellSpan York Hospital. He also serves as a member of the Executive Council for the Pennsylvania Chapter of the American College of Cardiology.
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional...
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Dr. Rinaldi has worked as an interventional cardiologist and vascular interventionalist for the Sanger Heart and...
Dr. Rinaldi has worked as an interventional cardiologist and vascular interventionalist for the Sanger Heart and Vascular Institute (SHVI) at Carolinas Medical Center in Charlotte NC. He held the leadership position of Director of Clinical Research for SHVI for over a decade. He holds an appointment as Professor of Medicine at UNC. He earned his medical degree from Cornell University and completed his internal medicine residency and cardiology and interventional cardiology fellowships at Beth Israel Deaconess Medical Center / Harvard Medical School in Boston, MA. He also completed a Peripheral Vascular Medicine Fellowship at St. Elizabeth's Medical Center in Boston and the Course in Clinical Effectiveness from the Harvard School of Public Health. He has served as an investigator for more than 50 clinical trials and has authored or co-authored more than 60 publications and 90 abstracts including in journals such as the NEJM, Lancet, JACC, and Circulation. He has served on faculty at most major cardiovascular conference in the US and serves on the DSMB and CEC of several clinical trials. He holds expertise in the fields of coronary intervention, peripheral intervention, and structural heart intervention including trans-catheter mitral valve repair, transcatheter aortic valve replacement and left atrial appendage occlusion.
Robert Lederman works at National Institutes of Health/National Heart, Lung, and Blood Institute, Bethesda, MD, USA.